Ligand Pharmaceuticals Inc. LGND
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ligand Pharmaceuticals Inc. is a biopharmaceutical company that develops, acquires, and out-licenses proprietary technologies to assist pharmaceutical and biotechnology firms in discovering and developing novel medicines. It operates through research services and royalty-generating businesses, focusing on a diversified…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees47
TickerLGND
Statistics
Market Cap$5.29B
Revenue (TTM)$268.1M
Net Income$124.5M
Net Margin46.4%
EPS$6.13
P/E33.19
P/S18.59
P/B5.11
EV/EBITDA34.57
ROE17.1%
Dividend Yield—
Price$263.95
Data: Twelve Data · Revenue = mcap / P/S